Christine Parseghian, MD
@ParseghianC
Followers
506
Following
214
Media
5
Statuses
50
Gastrointestinal Medical Oncologist at UT MD Anderson Cancer Center specializing in translational and clinical research in colorectal cancer. Tweets are my own.
Houston, TX
Joined June 2018
RT @realbowtiedoc: Dr @ParseghianC with a beautiful summary after her #crcsm trials for #BoA25 about the #future of our field including mor….
0
4
0
RT @realbowtiedoc: Dr @ParseghianC kicks off #BoA25 with the best in #crcsm trials from #ASCO25 starting off with the #BREAKWATER data #GIo….
0
3
0
RT @MDAndersonNews: What are the most provoking and practice-changing studies being presented in colorectal and anal cancer at #ASCO25? Our….
0
2
0
The incidence of young-onset colorectal cancer is frighteningly increasing over the last few decades. I share a few reasons in this interview, while telling the story of a fearless fighter patient of mine, graciously sharing his story. @MDAndersonNews #CRC
healthline.com
While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk. Additionally, making lifestyle changes can also help reduce your risk for CRC.
0
0
1
RT @CathyEngMD: What a way to close @ASCO #ASCOGI25! Have an informal gathering of friends to celebrate everyone’s achievements! #promoti….
0
4
0
Had the honor of co-chairing and presenting about novel therapeutics in colorectal cancer this weekend at the @myESMO conference in Barcelona! So many exciting advances, but so much left to do! @MDAndersonNews @FightCRC #ESMO2024
1
0
12
RT @alfaro_kristin: Use of serial ctDNA in metastatic #CRC to refine patient selection, reduce toxicity from chemotherapy & evaluate emergi….
aacrjournals.org
Summary. Promising utility of using serial ctDNA in metastatic colorectal cancer to both refine patient selection, reduce toxicity due to chemotherapy, and to evaluate emerging resistance mechanisms...
0
5
0
RT @skopetz: 🎉⭐️Major implications for understanding CRC biology & rechallenge studies! Resistance Mechanisms to Anti-EGFR Therapy in RAS/R….
pubmed.ncbi.nlm.nih.gov
These findings support a model of resistance whereby transcriptomic mechanisms of resistance predominate in the presence of active cytotoxic chemotherapy combined with EGFRi, with a greater predomi...
0
15
0
Inspiring stories like this, and incredible and brave patients like @BenTerryKPLC keep me fighting every day against this terrible disease. #fightcrc @MDAndersonNews
kplctv.com
“At this point, we were literally just rolling the dice, playing games with different chemo cocktails not knowing what, if any, would even work. It was really all we had left to try, and I was all in...
3
5
21
Words cannot express the impact Dr. V had on her patients and colleagues. She was a beautiful physician and a loving mother. I will forever be grateful for her mentorship and guidance. Rest In Peace, Dr. V. You will be deeply missed.
Gauri Varadhachary, fantastic clinician, physician leader, colleague, friend. We will miss you, Rest In Peace.
1
0
6
My mentor, @skopetz, sharing exciting updated results from the BEACON study finding no OS benefit with triplet regimen of enco + cetux + bini vs enco + cetux alone.
1
2
16
Thank you to @michael_overman and @skopetz for their continued mentorship on this and many other projects! #CRC #colorectalcancer @MDAndersonNews.
0
0
0
Just published in @JAMAOnc . Despite ethical obligations to report research biopsies, only 51% of all trials that included a research biopsy–related end point in CTG reported on these biopsy-related results. We must do better for our patients!
jamanetwork.com
This study searched ClinicalTrials.gov to examine the reporting rates of research biopsies conducted in oncology clinical trials amd investigates what factors correlate with research biopsy reporting.
1
12
43
RT @VanMorrisMD: So exciting to see BRAF/EGFR/MEK combo get #breakthrough designation by FDA for #BRAF mut #colorectalcancer. MAJOR advanc….
0
12
0
Great new trial @MDAndersonNews for patients with metastatic colon or rectal cancer to the lung! #coloncancer #rectalcancer #cancer #mdanderson #clinicaltrials @maraantonoff @VanMorrisMD.
We have a new trial available for patients with colon or rectal cancer metastasized to the lung. Patients, caregivers, and clinicians—check out the link for more details. #endcancer #crcsm @CathyEngMD @VanMorrisMD @AraVaporciyan @MDAndersonTrial
0
2
9
RT @Cancer_Cell: Bardelli & co. investigate the radiologic and genomic evolution of individual metastases during HER2 blockade in colorecta….
0
37
0
RT @VanMorrisMD: Excited to see the FDA approve nivo + ipi for MSI-High #crcsm. Congrats to the @MDAndersonNews team that led this great w….
0
6
0
Colorectal cancer is being diagnosed in a greater number of patients younger than 50 than ever before. Get your colonoscopies at age 45 per new guidelines and PREVENT this deadly disease! #coloncancer #prevention #cancer
According to a study, Americans born in 1990 “have double the risk of colon cancer and quadruple the risk of rectal cancer compared to people born around 1950.” #getscreened #coloncancerawareness
0
3
5